The syrup that Health has ordered to withdraw due to defects

The has issued an alert through its digital portal to inform that it has requested the withdrawal of a syrup due to problems with the product. Specifically, it is Vimpat 10.g/ml syrup, 1 bottle of 200 ml. “Vimpat contains lacosamide, which belongs to a group of medicines called “antiepileptic drugs”. These drugs are used to treat epilepsy.” as they explain from the AEMPS.

This syrup is used: “in adults, adolescents and children from 4 years to treat a certain type of epilepsy characterized by the appearance of partial onset seizures with or without secondary generalization”. “In this type of epilepsy, the seizures first affect only one side of your brain. However, they can then spread to larger areas on both sides of your brain. Vimpat can be used alone or together with other antiepileptic medicines.

He main reason for withdrawal of this product, as explained by the Spanish Agency for Medicines and Health Products, is due to the “absence of a dosing syringe in the medicine”. For this reason, this body has adopted as a precautionary measure the “Withdrawal from the market of all distributed units of lot 5845802 and return to the laboratory through the usual channels.” Likewise, the competent bodies of each autonomous community have been requested to monitor the withdrawal of this product.

The AEMPS, as state agency attached to the Ministry of Health, Consumption and Social Welfare, is responsible for guaranteeing to society, from the perspective of public service, the quality, safety, efficacy and correct information of medicines and health products, from their research to their use, in the interest of protecting and promoting human health, animal health and the environment. Among its main objectives are “the supervision of the supply and supply of medicines” and “the continuous monitoring of the safety and efficacy of medicines once they are marketed and the control of their quality” . Just a few days ago, this same body issued an informative alert through its digital portal to request the withdrawal of a medicine used to treat patients suffering from symptoms of heart failure and which is also used for patients with hypertension

See also  Twelve foods you have to buy if you want to lose weight (and fat)